查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
紫杉烷的全球市場 - 產業趨勢和至2029年的預測
市場調查報告書
商品編碼
1102207

紫杉烷的全球市場 - 產業趨勢和至2029年的預測

Global Taxane Market - Industry Trends and Forecast to 2029
出版日期: | 出版商: Data Bridge Market Research | 英文 396 Pages | 商品交期: 請詢問到貨日

價格

全球紫杉烷的市場規模，預計2022年～2029年的預測期間以7.6％的年複合成長率擴大。

本報告提供全球紫杉烷市場相關調查，市場概要，以及各類型，各用途，各藥物類型，各製劑，各年齡層，各終端用戶，各流通管道，各地區的趨勢，及加入此市場的主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

第5章 流行病學

第6章 產業洞察

第7章 全球紫杉烷市場:法規

第8章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第9章 全球紫杉烷市場，各類型

  • 概要
  • Paclitaxel
  • Docetaxel
  • Cabazitaxel

第10章 全球紫杉烷市場，各用途

  • 概要
  • 乳癌
  • 非小細胞肺癌
  • 胰臟癌
  • 卵巢癌
  • 前列腺癌
  • 其他

第11章 全球紫杉烷市場，各藥物類型

  • 概要
  • 學名藥
  • 品牌藥

第12章 全球紫杉烷市場，各製劑

  • 概要
  • 微脂體
  • 奈米粒子
  • 高分子奈米微胞
  • 其他

第13章 全球紫杉烷市場，各年齡層

  • 概要
  • 成人
  • 老年人

第14章 全球紫杉烷市場，各終端用戶

  • 概要
  • 醫院
  • 門診外科中心
  • 專門診所
  • 其他

第15章 全球紫杉烷市場，各流通管道

  • 概要
  • 零售
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 直接競標

第16章 全球紫杉烷市場，各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第17章 全球紫杉烷市場:企業形勢

第18章 SWOT分析

第19章 企業簡介

  • BRISTOL-MYERS SQUIBB COMPANY
  • SANOFI-AVENTIS U.S. LLC
  • VIATRIS INC.
  • SANDOZ INTERNATIONAL GMBH
  • FRESENIUS KABI AG
  • HIKMA PHARMACEUTICALS PLC
  • ACCORD HEALTHCARE
  • AQVIDA GMBH
  • AUREATE HEALTHCARE
  • CIPLA INC.
  • DR. REDDY'S LABORATORIES LTD.
  • ELEVAR THERAPEUTICS
  • HETERO HEALTHCARE LIMITED.
  • HUIANG PHARMACEUTICAL CO LTD
  • INGENUS PHARMACEUTICALS, LLC
  • LUYE PHARMA GROUP
  • PANACEA BIOTEC
  • PFIZER INC.
  • RPG LIFE SCIENCES LIMITED
  • SAMARTH LIFE SCIENCES PVT. LTD.
  • SAMYANG HOLDINGS CORPORATION.
  • SHENZHEN MAIN LUCK PHAR MACEUTICALS INC.
  • TORRENT PHARMACEUTICALS LTD
  • TAXANE HEALTHCARE

第20章 問卷調查

第21章 相關報告

Global taxane market is projected to register a substantial CAGR of 7.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.

Market Segmentation:

Global Taxane Market, By Type (Paclitaxel, Docetaxel, Cabazitaxel), Drug Type (Generics, Branded), Formulation (Liposomes, Nanoparticles, Polymeric Micelles, Others), Age Group (Adults, Geriatric), Application (Breast Cancer, Non-Small Lung Cancer, Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) Distribution Channel (Retail Sales, Direct Tender), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Austria, Hungary, Lithuania, Norway, Ireland, Rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, UAE, Egypt, Israel, South Africa, Kuwait, Rest of Middle East and Africa, Brazil, Argentina, Peru, and Rest of South America) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the global taxane market are:

The rise in the incidence of cancer

The funding by the government and investment in research and development

Market Segmentation:

Global taxane market is categorized into seven notable segment which are based on type, drug type, formulation, age group, application, end user and distribution channel

On the basis of type, the global taxane market is segmented into paclitaxel, docetaxel and cabazitaxel

On the basis of application, the global taxane market is segmented into ovarian cancer, breast cancer, prostate cancer, non-small cell lung cancer and other

On the basis of drug type, the global taxane market is segmented into branded and generics

On the basis of formulation, the global taxane market is segmented into liposomes, nanoparticles, polymeric micelles and others

On the basis of age group, the global taxane market is segmented into adults and geriatric

On the basis of end user, the global taxane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others

On the basis of distribution channel, the global taxane market is segmented into direct tender, retail sales

Market Players:

The key market players for global taxane market are listed below:

Viatris Inc.

Sandoz International GmbH ( A Novartis Division)

sanofi-aventis U.S. LLC

Hikma Pharmaceuticals PLC

Pfizer Inc.

Dr. Reddy's Laboratories Ltd.

Taxane Healthcare

Bristol-Myers Squibb Company

Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA )

SAMYANG HOLDINGS CORPORATION.

Luye Pharma Group

Elevar Therapeutics

Huiang Pharmaceutical Co Ltd.

Shenzhen Main Luck Phar maceuticals Inc.

Accord Healthcare

Torrent Pharmaceuticals Ltd.

Panacea Biotec

RPG Life Sciences Limited.

Aureate Healthcare

Samarth Life Sciences Pvt. Ltd.

Cipla Inc.

Hetero Healthcare Limited.

AqVida GmbH

Ingenus Pharmaceuticals, LLC

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL TAXANE MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 MARKET APPLICATION COVERAGE GRID
  • 2.8 TYPE LIFELINE CURVE
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

  • 4.1 PESTEL_ANALYSIS
  • 4.2 PORTER'S FIVE FORCES MODEL

5 EPIDEMIOLOGY

6 INDUSTRIAL INSIGHTS

  • 6.1 CONCLUSION

7 GLOBAL TAXANE MARKET: REGULATIONS

8 MARKET OVERVIEW

  • 8.1 DRIVERS
    • 8.1.1 THE RISE IN INCIDENCE OF CANCER
    • 8.1.2 THE FUNDING BY THE GOVERNMENT AND INVESTMENT IN RESEARCH AND DEVELOPMENT
    • 8.1.3 RISE IN PIPELINE OR CLINICAL TRIALS OF TAXANE TREATMENTS
    • 8.1.4 USE OF REIMBURSEMENT FOR TAXANE
  • 8.2 RESTRAINTS
    • 8.2.1 SIDE EFFECTS OF DRUGS INCURRED WITH THE TAXANE DRUGS
    • 8.2.2 ETHICAL ISSUES RELATED TO THE USE OF TAXANE TREATMENT
    • 8.2.3 RISE IN PRODUCT RECALLS
  • 8.3 OPPORTUNITIES
    • 8.3.1 STRATEGIC INITIATIVE BY MARKET PLAYERS
    • 8.3.2 RISE IN HEALTHCARE EXPENDITURE
  • 8.4 CHALLENGES
    • 8.4.1 THE LACK OF SKILLED PROFESSIONALS REQUIRED FOR TAXANE DRUG TREATMENT
    • 8.4.2 STRINGENT GOVERNMENT REGULATIONS ON TAXANE DRUG TREATMENT

9 GLOBAL TAXANE MARKET, BY TYPE

  • 9.1 OVERVIEW
  • 9.2 PACLITAXEL
    • 9.2.1 BY TYPE
      • 9.2.1.1 SEMI-SYNTHETIC
      • 9.2.1.2 NATURAL
    • 9.2.2 BY STRENGTH
      • 9.2.2.1 100MG
      • 9.2.2.2 200MG
      • 9.2.2.3 250MG
      • 9.2.2.4 30MG
      • 9.2.2.5 260MG
      • 9.2.2.6 300MG
  • 9.3 DOCETAXEL
    • 9.3.1 120MG
    • 9.3.2 80MG
    • 9.3.3 20MG
    • 9.3.4 40MG
    • 9.3.5 60MG
  • 9.4 CABAZITAXEL
    • 9.4.1 60MG

10 GLOBAL TAXANE MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 BREAST CANCER
  • 10.3 NON-SMALL CELL LUNG CANCER
  • 10.4 PANCREATIC CANCER
  • 10.5 OVARIAN CANCER
  • 10.6 PROSTATE CANCER
  • 10.7 OTHERS

11 GLOBAL TAXANE MARKET, BY DRUG TYPE

  • 11.1 OVERVIEW
  • 11.2 GENERICS
  • 11.3 BRANDED

12 GLOBAL TAXANE MARKET, BY FORMULATION

  • 12.1 OVERVIEW
  • 12.2 LIPOSOMES
  • 12.3 NANOPARTICLES
  • 12.4 POLYMERIC MICELLES
  • 12.5 OTHERS

13 GLOBAL TAXANE MARKET, BY AGE GROUP

  • 13.1 OVERVIEW
  • 13.2 ADULT
    • 13.2.1 FEMALE
    • 13.2.2 MALE
  • 13.3 GERIATRIC
    • 13.3.1 FEMALE
    • 13.3.2 MALE

14 GLOBAL TAXANE MARKET, BY END USER

  • 14.1 OVERVIEW
  • 14.2 HOSPITALS
  • 14.3 AMBULATORY SURGICAL CENTERS
  • 14.4 SPECIALTY CLINICS
  • 14.5 OTHERS

15 GLOBAL TAXANE MARKET, BY DISTRIBUTION CHANNEL

  • 15.1 OVERVIEW
  • 15.2 RETAIL SALES
    • 15.2.1 HOSPITAL PHARMACY
    • 15.2.2 RETAIL PHARMACY
    • 15.2.3 ONLINE PHARMACY
  • 15.3 DIRECT TENDER

16 GLOBAL TAXANE MARKET, BY REGION

  • 16.1 OVERVIEW
  • 16.2 NORTH AMERICA
    • 16.2.1 U.S.
    • 16.2.2 CANADA
    • 16.2.3 MEXICO
  • 16.3 EUROPE
    • 16.3.1 GERMANY
    • 16.3.2 FRANCE
    • 16.3.3 U.K.
    • 16.3.4 ITALY
    • 16.3.5 RUSSIA
    • 16.3.6 SPAIN
    • 16.3.7 TURKEY
    • 16.3.8 NETHERLANDS
    • 16.3.9 SWITZERLAND
    • 16.3.10 POLAND
    • 16.3.11 BELGIUM
    • 16.3.12 HUNGARY
    • 16.3.13 AUSTRIA
    • 16.3.14 NORWAY
    • 16.3.15 IRELAND
    • 16.3.16 LITHUANIA
    • 16.3.17 REST OF EUROPE
  • 16.4 ASIA-PACIFIC
    • 16.4.1 CHINA
    • 16.4.2 JAPAN
    • 16.4.3 INDIA
    • 16.4.4 SOUTH KOREA
    • 16.4.5 AUSTRALIA
    • 16.4.6 INDONESIA
    • 16.4.7 THAILAND
    • 16.4.8 PHILIPPINES
    • 16.4.9 VIETNAM
    • 16.4.10 SINGAPORE
    • 16.4.11 MALAYSIA
    • 16.4.12 REST OF ASIA-PACIFIC
  • 16.5 SOUTH AMERICA
    • 16.5.1 BRAZIL
    • 16.5.2 ARGENTINA
    • 16.5.3 PERU
    • 16.5.4 REST OF SOUTH AMERICA
  • 16.6 MIDDLE EAST AND AFRICA
    • 16.6.1 SOUTH AFRICA
    • 16.6.2 EGYPT
    • 16.6.3 SAUDI ARABIA
    • 16.6.4 U.A.E
    • 16.6.5 ISRAEL
    • 16.6.6 KUWAIT
    • 16.6.7 REST OF MIDDLE EAST AND AFRICA

17 GLOBAL TAXANE MARKET: COMPANY LANDSCAPE

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 17.3 COMPANY SHARE ANALYSIS: EUROPE
  • 17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

18 SWOT ANALYSIS

19 COMPANY PROFILE

  • 19.1 BRISTOL-MYERS SQUIBB COMPANY
    • 19.1.1 COMPANY SNAPSHOT
    • 19.1.2 REVENUE ANALYSIS
    • 19.1.3 COMPANY SHARE ANALYSIS
    • 19.1.4 PRODUCT PORTFOLIO
    • 19.1.5 RECENT DEVELOPMENTS
  • 19.2 SANOFI-AVENTIS U.S. LLC
    • 19.2.1 COMPANY SNAPSHOT
    • 19.2.2 REVENUE ANALYSIS
    • 19.2.3 COMPANY SHARE ANALYSIS
    • 19.2.4 PRODUCT PORTFOLIO
    • 19.2.5 RECENT DEVELOPMENTS
  • 19.3 VIATRIS INC.
    • 19.3.1 COMPANY SNAPSHOT
    • 19.3.2 REVENUE ANALYSIS
    • 19.3.3 COMPANY SHARE ANALYSIS
    • 19.3.4 PRODUCT PORTFOLIO
    • 19.3.5 RECENT DEVELOPMENT
  • 19.4 SANDOZ INTERNATIONAL GMBH (A NOVARTIS DIVISION)
    • 19.4.1 COMPANY SNAPSHOT
    • 19.4.2 REVENUE ANALYSIS
    • 19.4.3 COMPANY SHARE ANALYSIS
    • 19.4.4 PRODUCT PORTFOLIO
    • 19.4.5 RECENT DEVELOPMENTS
  • 19.5 FRESENIUS KABI AG (SUBSIDIARY OF FRESENIUS SE & CO. KGAA )
    • 19.5.1 COMPANY SNAPSHOT
    • 19.5.2 REVENUE ANALYSIS
    • 19.5.3 COMPANY SHARE ANALYSIS
    • 19.5.4 PRODUCT PORTFOLIO
    • 19.5.5 RECENT DEVELOPMENTS
  • 19.6 HIKMA PHARMACEUTICALS PLC
    • 19.6.1 COMPANY SNAPSHOT
    • 19.6.2 REVENUE ANALYSIS
    • 19.6.3 PRODUCT PORTFOLIO
    • 19.6.4 RECENT DEVELOPMENTS
  • 19.7 ACCORD HEALTHCARE
    • 19.7.1 COMPANY SNAPSHOT
    • 19.7.2 PRODUCT PORTFOLIO
    • 19.7.3 RECENT DEVELOPMENTS
  • 19.8 AQVIDA GMBH
    • 19.8.1 COMPANY SNAPSHOT
    • 19.8.2 PRODUCT PORTFOLIO
    • 19.8.3 RECENT DEVELOPMENTS
  • 19.9 AUREATE HEALTHCARE
    • 19.9.1 COMPANY SNAPSHOT
    • 19.9.2 PRODUCT PORTFOLIO
    • 19.9.3 RECENT DEVELOPMENTS
  • 19.10 CIPLA INC.
    • 19.10.1 COMPANY SNAPSHOT
    • 19.10.2 REVENUE ANALYSIS
    • 19.10.3 PRODUCT PORTFOLIO
    • 19.10.4 RECENT DEVELOPMENTS
  • 19.11 DR. REDDY'S LABORATORIES LTD.
    • 19.11.1 COMPANY SNAPSHOT
    • 19.11.2 REVENUE ANALYSIS
    • 19.11.3 PRODUCT PORTFOLIO
    • 19.11.4 RECENT DEVELOPMENTS
  • 19.12 ELEVAR THERAPEUTICS
    • 19.12.1 COMPANY SNAPSHOT
    • 19.12.2 PRODUCT PORTFOLIO
    • 19.12.3 RECENT DEVELOPMENTS
  • 19.13 HETERO HEALTHCARE LIMITED.
    • 19.13.1 COMPANY SNAPSHOT
    • 19.13.2 PRODUCT PORTFOLIO
    • 19.13.3 RECENT DEVELOPMENTS
  • 19.14 HUIANG PHARMACEUTICAL CO LTD
    • 19.14.1 COMPANY SNAPSHOT
    • 19.14.2 PRODUCT PORTFOLIO
    • 19.14.3 RECENT DEVELOPMENTS
  • 19.15 INGENUS PHARMACEUTICALS, LLC
    • 19.15.1 COMPANY SNAPSHOT
    • 19.15.2 PRODUCT PORTFOLIO
    • 19.15.3 RECENT DEVELOPMENTS
  • 19.16 LUYE PHARMA GROUP
    • 19.16.1 COMPANY SNAPSHOT
    • 19.16.2 REVENUE ANALYSIS
    • 19.16.3 PRODUCT PORTFOLIO
    • 19.16.4 RECENT DEVELOPMENTS
  • 19.17 PANACEA BIOTEC
    • 19.17.1 COMPANY SNAPSHOT
    • 19.17.2 REVENUE ANALYSIS
    • 19.17.3 PRODUCT PORTFOLIO
    • 19.17.4 RECENT DEVELOPMENTS
  • 19.18 PFIZER INC.
    • 19.18.1 COMPANY SNAPSHOT
    • 19.18.2 REVENUE ANALYSIS
    • 19.18.3 PRODUCT PORTFOLIO
    • 19.18.4 RECENT DEVELOPMENTS
  • 19.19 RPG LIFE SCIENCES LIMITED
    • 19.19.1 COMPANY SNAPSHOT
    • 19.19.2 REVENUE ANALYSIS
    • 19.19.3 PRODUCT PORTFOLIO
    • 19.19.4 RECENT DEVELOPMENTS
  • 19.20 SAMARTH LIFE SCIENCES PVT. LTD.
    • 19.20.1 COMPANY SNAPSHOT
    • 19.20.2 PRODUCT PORTFOLIO
    • 19.20.3 RECENT DEVELOPMENTS
  • 19.21 SAMYANG HOLDINGS CORPORATION.
    • 19.21.1 COMPANY SNAPSHOT
    • 19.21.2 REVENUE ANALYSIS
    • 19.21.3 PRODUCT PORTFOLIO
    • 19.21.4 RECENT DEVELOPMENTS
  • 19.22 SHENZHEN MAIN LUCK PHAR MACEUTICALS INC.
    • 19.22.1 COMPANY SNAPSHOT
    • 19.22.2 PRODUCT PORTFOLIO
    • 19.22.3 RECENT DEVELOPMENTS
  • 19.23 TORRENT PHARMACEUTICALS LTD
    • 19.23.1 COMPANY SNAPSHOT
    • 19.23.2 REVENUE ANALYSIS
    • 19.23.3 PRODUCT PORTFOLIO
    • 19.23.4 RECENT DEVELOPMENTS
  • 19.24 TAXANE HEALTHCARE
    • 19.24.1 COMPANY SNAPSHOT
    • 19.24.2 PRODUCT PORTFOLIO
    • 19.24.3 RECENT DEVELOPMENTS

20 QUESTIONNAIRE

21 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 GLOBAL TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 86
  • TABLE 2 GLOBAL PACLITAXEL IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 87
  • TABLE 3 GLOBAL PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 87
  • TABLE 4 GLOBAL PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 88
  • TABLE 5 GLOBAL DOCETAXEL IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 89
  • TABLE 6 GLOBAL DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 89
  • TABLE 7 GLOBAL CABAZITAXEL IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 90
  • TABLE 8 GLOBAL CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 91
  • TABLE 9 GLOBAL TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 95
  • TABLE 10 GLOBAL BREAST CANCER IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 96
  • TABLE 11 GLOBAL NON-SMALL LUNG CANCER IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 97
  • TABLE 12 GLOBAL PANCREATIC CANCER IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 97
  • TABLE 13 GLOBAL OVARIAN CANCER IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 98
  • TABLE 14 GLOBAL PROSTATE CANCER IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 99
  • TABLE 15 GLOBAL OTHERS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 99
  • TABLE 16 GLOBAL TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 103
  • TABLE 17 GLOBAL GENERICS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 104
  • TABLE 18 GLOBAL BRANDED IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 105
  • TABLE 19 GLOBAL TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 109
  • TABLE 20 GLOBAL LIPOSOMES IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 110
  • TABLE 21 GLOBAL NANOPARTICLES IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 111
  • TABLE 22 GLOBAL POLYMERIC MICELLES IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 111
  • TABLE 23 GLOBAL OTHERS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 112
  • TABLE 24 GLOBAL TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 116
  • TABLE 25 GLOBAL ADULT IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 117
  • TABLE 26 GLOBAL ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 117
  • TABLE 27 GLOBAL GERIATRIC IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 118
  • TABLE 28 GLOBAL GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 119
  • TABLE 29 GLOBAL TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 123
  • TABLE 30 GLOBAL HOSPITALS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 124
  • TABLE 31 GLOBAL AMBULATORY SURGICAL CENTERS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 125
  • TABLE 32 GLOBAL SPECIALTY CLINICS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 125
  • TABLE 33 GLOBAL OTHERS IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 126
  • TABLE 34 GLOBAL TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 130
  • TABLE 35 GLOBAL RETAIL SALES IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 131
  • TABLE 36 GLOBAL RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 131
  • TABLE 37 GLOBAL DIRECT TENDER IN TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 132
  • TABLE 38 GLOBAL TAXANE MARKET, BY REGION, 2020-2029 (USD MILLION) 139
  • TABLE 39 NORTH AMERICA TAXANE MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 145
  • TABLE 40 NORTH AMERICA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 145
  • TABLE 41 NORTH AMERICA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 145
  • TABLE 42 NORTH AMERICA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 145
  • TABLE 43 NORTH AMERICA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 44 NORTH AMERICA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 146
  • TABLE 45 NORTH AMERICA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 146
  • TABLE 46 NORTH AMERICA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 146
  • TABLE 47 NORTH AMERICA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 147
  • TABLE 48 NORTH AMERICA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 147
  • TABLE 49 NORTH AMERICA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 147
  • TABLE 50 NORTH AMERICA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 147
  • TABLE 51 NORTH AMERICA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 147
  • TABLE 52 NORTH AMERICA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 148
  • TABLE 53 NORTH AMERICA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 148
  • TABLE 54 U.S. TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 149
  • TABLE 55 U.S. PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 149
  • TABLE 56 U.S. TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 149
  • TABLE 57 U.S. TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 149
  • TABLE 58 U.S. TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 150
  • TABLE 59 U.S. PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 150
  • TABLE 60 U.S. DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 150
  • TABLE 61 U.S. CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 150
  • TABLE 62 U.S. TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 151
  • TABLE 63 U.S. ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 151
  • TABLE 64 U.S. GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 151
  • TABLE 65 U.S. TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 151
  • TABLE 66 U.S. TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 151
  • TABLE 67 U.S. RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 152
  • TABLE 68 CANADA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 69 CANADA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 70 CANADA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 153
  • TABLE 71 CANADA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 72 CANADA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 154
  • TABLE 73 CANADA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 154
  • TABLE 74 CANADA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 154
  • TABLE 75 CANADA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 154
  • TABLE 76 CANADA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 155
  • TABLE 77 CANADA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 155
  • TABLE 78 CANADA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 155
  • TABLE 79 CANADA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 155
  • TABLE 80 CANADA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 155
  • TABLE 81 CANADA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 156
  • TABLE 82 MEXICO TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 83 MEXICO PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 84 MEXICO TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 157
  • TABLE 85 MEXICO TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 86 MEXICO TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 158
  • TABLE 87 MEXICO PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 158
  • TABLE 88 MEXICO DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 158
  • TABLE 89 MEXICO CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 158
  • TABLE 90 MEXICO TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 159
  • TABLE 91 MEXICO ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 159
  • TABLE 92 MEXICO GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 159
  • TABLE 93 MEXICO TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 159
  • TABLE 94 MEXICO TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 159
  • TABLE 95 MEXICO RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 160
  • TABLE 96 EUROPE TAXANE MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 166
  • TABLE 97 EUROPE TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 166
  • TABLE 98 EUROPE PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 166
  • TABLE 99 EUROPE TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 167
  • TABLE 100 EUROPE TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 167
  • TABLE 101 EUROPE TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 167
  • TABLE 102 EUROPE PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 167
  • TABLE 103 EUROPE DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 168
  • TABLE 104 EUROPE CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 168
  • TABLE 105 EUROPE TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 168
  • TABLE 106 EUROPE ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 168
  • TABLE 107 EUROPE GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 168
  • TABLE 108 EUROPE TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 169
  • TABLE 109 EUROPE TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 169
  • TABLE 110 EUROPE RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 169
  • TABLE 111 GERMANY TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 112 GERMANY PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 113 GERMANY TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 170
  • TABLE 114 GERMANY TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 115 GERMANY TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 171
  • TABLE 116 GERMANY PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 171
  • TABLE 117 GERMANY DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 171
  • TABLE 118 GERMANY CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 171
  • TABLE 119 GERMANY TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 172
  • TABLE 120 GERMANY ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 172
  • TABLE 121 GERMANY GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 172
  • TABLE 122 GERMANY TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 172
  • TABLE 123 GERMANY TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 172
  • TABLE 124 GERMANY RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 173
  • TABLE 125 FRANCE TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 126 FRANCE PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 127 FRANCE TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 174
  • TABLE 128 FRANCE TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 129 FRANCE TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 175
  • TABLE 130 FRANCE PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 175
  • TABLE 131 FRANCE DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 175
  • TABLE 132 FRANCE CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 175
  • TABLE 133 FRANCE TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 176
  • TABLE 134 FRANCE ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 176
  • TABLE 135 FRANCE GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 176
  • TABLE 136 FRANCE TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 176
  • TABLE 137 FRANCE TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 176
  • TABLE 138 FRANCE RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 177
  • TABLE 139 U.K. TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 178
  • TABLE 140 U.K. PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 178
  • TABLE 141 U.K. TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 178
  • TABLE 142 U.K. TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 178
  • TABLE 143 U.K. TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 179
  • TABLE 144 U.K. PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 179
  • TABLE 145 U.K. DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 179
  • TABLE 146 U.K. CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 179
  • TABLE 147 U.K. TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 180
  • TABLE 148 U.K. ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 180
  • TABLE 149 U.K. GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 180
  • TABLE 150 U.K. TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 180
  • TABLE 151 U.K. TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 180
  • TABLE 152 U.K. RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 181
  • TABLE 153 ITALY TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 154 ITALY PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 155 ITALY TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 182
  • TABLE 156 ITALY TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 157 ITALY TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 183
  • TABLE 158 ITALY PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 183
  • TABLE 159 ITALY DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 183
  • TABLE 160 ITALY CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 183
  • TABLE 161 ITALY TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 184
  • TABLE 162 ITALY ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 184
  • TABLE 163 ITALY GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 184
  • TABLE 164 ITALY TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 184
  • TABLE 165 ITALY TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 184
  • TABLE 166 ITALY RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 185
  • TABLE 167 RUSSIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 186
  • TABLE 168 RUSSIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 186
  • TABLE 169 RUSSIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 186
  • TABLE 170 RUSSIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 186
  • TABLE 171 RUSSIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 187
  • TABLE 172 RUSSIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 187
  • TABLE 173 RUSSIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 187
  • TABLE 174 RUSSIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 187
  • TABLE 175 RUSSIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 188
  • TABLE 176 RUSSIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 188
  • TABLE 177 RUSSIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 188
  • TABLE 178 RUSSIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 188
  • TABLE 179 RUSSIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 188
  • TABLE 180 RUSSIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 189
  • TABLE 181 SPAIN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 190
  • TABLE 182 SPAIN PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 190
  • TABLE 183 SPAIN TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 190
  • TABLE 184 SPAIN TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 190
  • TABLE 185 SPAIN TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 191
  • TABLE 186 SPAIN PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 191
  • TABLE 187 SPAIN DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 191
  • TABLE 188 SPAIN CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 191
  • TABLE 189 SPAIN TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 192
  • TABLE 190 SPAIN ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 192
  • TABLE 191 SPAIN GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 192
  • TABLE 192 SPAIN TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 192
  • TABLE 193 SPAIN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 192
  • TABLE 194 SPAIN RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 193
  • TABLE 195 TURKEY TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 194
  • TABLE 196 TURKEY PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 194
  • TABLE 197 TURKEY TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 194
  • TABLE 198 TURKEY TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 194
  • TABLE 199 TURKEY TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 195
  • TABLE 200 TURKEY PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 195
  • TABLE 201 TURKEY DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 195
  • TABLE 202 TURKEY CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 195
  • TABLE 203 TURKEY TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 196
  • TABLE 204 TURKEY ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 196
  • TABLE 205 TURKEY GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 196
  • TABLE 206 TURKEY TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 196
  • TABLE 207 TURKEY TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 196
  • TABLE 208 TURKEY RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 197
  • TABLE 209 NETHERLANDS TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 210 NETHERLANDS PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 211 NETHERLANDS TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 198
  • TABLE 212 NETHERLANDS TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 213 NETHERLANDS TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 199
  • TABLE 214 NETHERLANDS PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 199
  • TABLE 215 NETHERLANDS DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 199
  • TABLE 216 NETHERLANDS CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 199
  • TABLE 217 NETHERLANDS TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 200
  • TABLE 218 NETHERLANDS ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 200
  • TABLE 219 NETHERLANDS GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 200
  • TABLE 220 NETHERLANDS TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 200
  • TABLE 221 NETHERLANDS TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 200
  • TABLE 222 NETHERLANDS RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 201
  • TABLE 223 SWITZERLAND TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 224 SWITZERLAND PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 225 SWITZERLAND TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 202
  • TABLE 226 SWITZERLAND TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 227 SWITZERLAND TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 203
  • TABLE 228 SWITZERLAND PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 203
  • TABLE 229 SWITZERLAND DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 203
  • TABLE 230 SWITZERLAND CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 203
  • TABLE 231 SWITZERLAND TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 204
  • TABLE 232 SWITZERLAND ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 204
  • TABLE 233 SWITZERLAND GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 204
  • TABLE 234 SWITZERLAND TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 204
  • TABLE 235 SWITZERLAND TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 204
  • TABLE 236 SWITZERLAND RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 205
  • TABLE 237 POLAND TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 238 POLAND PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 239 POLAND TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 206
  • TABLE 240 POLAND TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 241 POLAND TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 207
  • TABLE 242 POLAND PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 207
  • TABLE 243 POLAND DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 207
  • TABLE 244 POLAND CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 207
  • TABLE 245 POLAND TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 208
  • TABLE 246 POLAND ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 208
  • TABLE 247 POLAND GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 208
  • TABLE 248 POLAND TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 208
  • TABLE 249 POLAND TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 208
  • TABLE 250 POLAND RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 209
  • TABLE 251 BELGIUM TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 252 BELGIUM PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 253 BELGIUM TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 210
  • TABLE 254 BELGIUM TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 255 BELGIUM TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 211
  • TABLE 256 BELGIUM PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 211
  • TABLE 257 BELGIUM DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 211
  • TABLE 258 BELGIUM CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 211
  • TABLE 259 BELGIUM TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 212
  • TABLE 260 BELGIUM ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 212
  • TABLE 261 BELGIUM GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 212
  • TABLE 262 BELGIUM TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 212
  • TABLE 263 BELGIUM TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 212
  • TABLE 264 BELGIUM RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 213
  • TABLE 265 HUNGARY TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 266 HUNGARY PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 267 HUNGARY TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 214
  • TABLE 268 HUNGARY TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 269 HUNGARY TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 215
  • TABLE 270 HUNGARY PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 215
  • TABLE 271 HUNGARY DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 215
  • TABLE 272 HUNGARY CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 215
  • TABLE 273 HUNGARY TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 216
  • TABLE 274 HUNGARY ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 216
  • TABLE 275 HUNGARY GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 216
  • TABLE 276 HUNGARY TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 216
  • TABLE 277 HUNGARY TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 216
  • TABLE 278 HUNGARY RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 217
  • TABLE 279 AUSTRIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 218
  • TABLE 280 AUSTRIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 218
  • TABLE 281 AUSTRIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 218
  • TABLE 282 AUSTRIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 218
  • TABLE 283 AUSTRIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 219
  • TABLE 284 AUSTRIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 219
  • TABLE 285 AUSTRIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 219
  • TABLE 286 AUSTRIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 219
  • TABLE 287 AUSTRIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 220
  • TABLE 288 AUSTRIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 220
  • TABLE 289 AUSTRIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 220
  • TABLE 290 AUSTRIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 220
  • TABLE 291 AUSTRIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 220
  • TABLE 292 AUSTRIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 221
  • TABLE 293 NORWAY TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 222
  • TABLE 294 NORWAY PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 222
  • TABLE 295 NORWAY TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 222
  • TABLE 296 NORWAY TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 222
  • TABLE 297 NORWAY TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 223
  • TABLE 298 NORWAY PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 223
  • TABLE 299 NORWAY DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 223
  • TABLE 300 NORWAY CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 223
  • TABLE 301 NORWAY TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 224
  • TABLE 302 NORWAY ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 224
  • TABLE 303 NORWAY GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 224
  • TABLE 304 NORWAY TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 224
  • TABLE 305 NORWAY TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 224
  • TABLE 306 NORWAY RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 225
  • TABLE 307 IRELAND TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 226
  • TABLE 308 IRELAND PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 226
  • TABLE 309 IRELAND TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 226
  • TABLE 310 IRELAND TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 226
  • TABLE 311 IRELAND TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 227
  • TABLE 312 IRELAND PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 227
  • TABLE 313 IRELAND DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 227
  • TABLE 314 IRELAND CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 227
  • TABLE 315 IRELAND TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 228
  • TABLE 316 IRELAND ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 228
  • TABLE 317 IRELAND GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 228
  • TABLE 318 IRELAND TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 228
  • TABLE 319 IRELAND TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 228
  • TABLE 320 IRELAND RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 229
  • TABLE 321 LITHUANIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 230
  • TABLE 322 LITHUANIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 230
  • TABLE 323 LITHUANIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 230
  • TABLE 324 LITHUANIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 230
  • TABLE 325 LITHUANIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 231
  • TABLE 326 LITHUANIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 231
  • TABLE 327 LITHUANIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 231
  • TABLE 328 LITHUANIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 231
  • TABLE 329 LITHUANIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 232
  • TABLE 330 LITHUANIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 232
  • TABLE 331 LITHUANIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 232
  • TABLE 332 LITHUANIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 232
  • TABLE 333 LITHUANIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 232
  • TABLE 334 LITHUANIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 233
  • TABLE 335 REST OF EUROPE TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 234
  • TABLE 336 ASIA-PACIFIC TAXANE MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 240
  • TABLE 337 ASIA-PACIFIC TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 240
  • TABLE 338 ASIA-PACIFIC PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 240
  • TABLE 339 ASIA-PACIFIC TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 241
  • TABLE 340 ASIA-PACIFIC TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 241
  • TABLE 341 ASIA-PACIFIC TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 241
  • TABLE 342 ASIA-PACIFIC PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 241
  • TABLE 343 ASIA-PACIFIC DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 242
  • TABLE 344 ASIA-PACIFIC CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 242
  • TABLE 345 ASIA-PACIFIC TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 242
  • TABLE 346 ASIA-PACIFIC ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 242
  • TABLE 347 ASIA-PACIFIC GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 242
  • TABLE 348 ASIA-PACIFIC TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 243
  • TABLE 349 ASIA-PACIFIC TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 243
  • TABLE 350 ASIA-PACIFIC RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 243
  • TABLE 351 CHINA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 244
  • TABLE 352 CHINA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 244
  • TABLE 353 CHINA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 244
  • TABLE 354 CHINA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 244
  • TABLE 355 CHINA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 245
  • TABLE 356 CHINA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 245
  • TABLE 357 CHINA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 245
  • TABLE 358 CHINA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 245
  • TABLE 359 CHINA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 246
  • TABLE 360 CHINA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 246
  • TABLE 361 CHINA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 246
  • TABLE 362 CHINA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 246
  • TABLE 363 CHINA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 246
  • TABLE 364 CHINA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 247
  • TABLE 365 JAPAN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 248
  • TABLE 366 JAPAN PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 248
  • TABLE 367 JAPAN TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 248
  • TABLE 368 JAPAN TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 248
  • TABLE 369 JAPAN TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 249
  • TABLE 370 JAPAN PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 249
  • TABLE 371 JAPAN DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 249
  • TABLE 372 JAPAN CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 249
  • TABLE 373 JAPAN TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 250
  • TABLE 374 JAPAN ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 250
  • TABLE 375 JAPAN GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 250
  • TABLE 376 JAPAN TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 250
  • TABLE 377 JAPAN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 250
  • TABLE 378 JAPAN RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 251
  • TABLE 379 INDIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 252
  • TABLE 380 INDIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 252
  • TABLE 381 INDIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 252
  • TABLE 382 INDIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 252
  • TABLE 383 INDIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 253
  • TABLE 384 INDIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 253
  • TABLE 385 INDIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 253
  • TABLE 386 INDIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 253
  • TABLE 387 INDIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 254
  • TABLE 388 INDIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 254
  • TABLE 389 INDIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 254
  • TABLE 390 INDIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 254
  • TABLE 391 INDIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 254
  • TABLE 392 INDIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 255
  • TABLE 393 SOUTH KOREA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 256
  • TABLE 394 SOUTH KOREA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 256
  • TABLE 395 SOUTH KOREA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 256
  • TABLE 396 SOUTH KOREA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 256
  • TABLE 397 SOUTH KOREA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 257
  • TABLE 398 SOUTH KOREA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 257
  • TABLE 399 SOUTH KOREA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 257
  • TABLE 400 SOUTH KOREA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 257
  • TABLE 401 SOUTH KOREA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 258
  • TABLE 402 SOUTH KOREA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 258
  • TABLE 403 SOUTH KOREA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 258
  • TABLE 404 SOUTH KOREA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 258
  • TABLE 405 SOUTH KOREA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 258
  • TABLE 406 SOUTH KOREA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 259
  • TABLE 407 AUSTRALIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 260
  • TABLE 408 AUSTRALIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 260
  • TABLE 409 AUSTRALIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 260
  • TABLE 410 AUSTRALIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 260
  • TABLE 411 AUSTRALIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 261
  • TABLE 412 AUSTRALIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 261
  • TABLE 413 AUSTRALIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 261
  • TABLE 414 AUSTRALIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 261
  • TABLE 415 AUSTRALIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 262
  • TABLE 416 AUSTRALIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 262
  • TABLE 417 AUSTRALIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 262
  • TABLE 418 AUSTRALIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 262
  • TABLE 419 AUSTRALIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 262
  • TABLE 420 AUSTRALIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 263
  • TABLE 421 INDONESIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 264
  • TABLE 422 INDONESIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 264
  • TABLE 423 INDONESIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 264
  • TABLE 424 INDONESIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 264
  • TABLE 425 INDONESIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 265
  • TABLE 426 INDONESIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 265
  • TABLE 427 INDONESIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 265
  • TABLE 428 INDONESIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 265
  • TABLE 429 INDONESIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 266
  • TABLE 430 INDONESIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 266
  • TABLE 431 INDONESIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 266
  • TABLE 432 INDONESIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 266
  • TABLE 433 INDONESIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 266
  • TABLE 434 INDONESIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 267
  • TABLE 435 THAILAND TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 268
  • TABLE 436 THAILAND PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 268
  • TABLE 437 THAILAND TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 268
  • TABLE 438 THAILAND TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 268
  • TABLE 439 THAILAND TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 269
  • TABLE 440 THAILAND PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 269
  • TABLE 441 THAILAND DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 269
  • TABLE 442 THAILAND CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 269
  • TABLE 443 THAILAND TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 270
  • TABLE 444 THAILAND ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 270
  • TABLE 445 THAILAND GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 270
  • TABLE 446 THAILAND TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 270
  • TABLE 447 THAILAND TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 270
  • TABLE 448 THAILAND RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 271
  • TABLE 449 PHILIPPINES TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 272
  • TABLE 450 PHILIPPINES PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 272
  • TABLE 451 PHILIPPINES TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 272
  • TABLE 452 PHILIPPINES TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 272
  • TABLE 453 PHILIPPINES TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 273
  • TABLE 454 PHILIPPINES PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 273
  • TABLE 455 PHILIPPINES DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 273
  • TABLE 456 PHILIPPINES CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 273
  • TABLE 457 PHILIPPINES TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 274
  • TABLE 458 PHILIPPINES ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 274
  • TABLE 459 PHILIPPINES GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 274
  • TABLE 460 PHILIPPINES TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 274
  • TABLE 461 PHILIPPINES TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 274
  • TABLE 462 PHILIPPINES RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 275
  • TABLE 463 VIETNAM TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 276
  • TABLE 464 VIETNAM PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 276
  • TABLE 465 VIETNAM TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 276
  • TABLE 466 VIETNAM TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 276
  • TABLE 467 VIETNAM TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 277
  • TABLE 468 VIETNAM PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 277
  • TABLE 469 VIETNAM DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 277
  • TABLE 470 VIETNAM CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 277
  • TABLE 471 VIETNAM TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 278
  • TABLE 472 VIETNAM ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 278
  • TABLE 473 VIETNAM GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 278
  • TABLE 474 VIETNAM TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 278
  • TABLE 475 VIETNAM TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 278
  • TABLE 476 VIETNAM RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 279
  • TABLE 477 SINGAPORE TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 280
  • TABLE 478 SINGAPORE PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 280
  • TABLE 479 SINGAPORE TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 280
  • TABLE 480 SINGAPORE TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 280
  • TABLE 481 SINGAPORE TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 281
  • TABLE 482 SINGAPORE PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 281
  • TABLE 483 SINGAPORE DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 281
  • TABLE 484 SINGAPORE CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 281
  • TABLE 485 SINGAPORE TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 282
  • TABLE 486 SINGAPORE ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 282
  • TABLE 487 SINGAPORE GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 282
  • TABLE 488 SINGAPORE TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 282
  • TABLE 489 SINGAPORE TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 282
  • TABLE 490 SINGAPORE RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 283
  • TABLE 491 MALAYSIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 284
  • TABLE 492 MALAYSIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 284
  • TABLE 493 MALAYSIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 284
  • TABLE 494 MALAYSIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 284
  • TABLE 495 MALAYSIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 285
  • TABLE 496 MALAYSIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 285
  • TABLE 497 MALAYSIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 285
  • TABLE 498 MALAYSIA CABAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 285
  • TABLE 499 MALAYSIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 286
  • TABLE 500 MALAYSIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 286
  • TABLE 501 MALAYSIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 286
  • TABLE 502 MALAYSIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 286
  • TABLE 503 MALAYSIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 286
  • TABLE 504 MALAYSIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 287
  • TABLE 505 REST OF ASIA-PACIFIC TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 288
  • TABLE 506 SOUTH AMERICA TAXANE MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 294
  • TABLE 507 SOUTH AMERICA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 294
  • TABLE 508 SOUTH AMERICA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 294
  • TABLE 509 SOUTH AMERICA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 294
  • TABLE 510 SOUTH AMERICA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 295
  • TABLE 511 SOUTH AMERICA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 295
  • TABLE 512 SOUTH AMERICA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 295
  • TABLE 513 SOUTH AMERICA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 295
  • TABLE 514 SOUTH AMERICA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 296
  • TABLE 515 SOUTH AMERICA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 296
  • TABLE 516 SOUTH AMERICA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 296
  • TABLE 517 SOUTH AMERICA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 296
  • TABLE 518 SOUTH AMERICA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 296
  • TABLE 519 SOUTH AMERICA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 297
  • TABLE 520 SOUTH AMERICA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 297
  • TABLE 521 BRAZIL TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 298
  • TABLE 522 BRAZIL PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 298
  • TABLE 523 BRAZIL TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 298
  • TABLE 524 BRAZIL TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 298
  • TABLE 525 BRAZIL TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 299
  • TABLE 526 BRAZIL PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 299
  • TABLE 527 BRAZIL DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 299
  • TABLE 528 BRAZIL CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 299
  • TABLE 529 BRAZIL TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 300
  • TABLE 530 BRAZIL ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 300
  • TABLE 531 BRAZIL GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 300
  • TABLE 532 BRAZIL TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 300
  • TABLE 533 BRAZIL TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 300
  • TABLE 534 BRAZIL RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 301
  • TABLE 535 ARGENTINA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 302
  • TABLE 536 ARGENTINA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 302
  • TABLE 537 ARGENTINA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 302
  • TABLE 538 ARGENTINA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 302
  • TABLE 539 ARGENTINA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 303
  • TABLE 540 ARGENTINA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 303
  • TABLE 541 ARGENTINA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 303
  • TABLE 542 ARGENTINA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 303
  • TABLE 543 ARGENTINA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 304
  • TABLE 544 ARGENTINA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 304
  • TABLE 545 ARGENTINA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 304
  • TABLE 546 ARGENTINA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 304
  • TABLE 547 ARGENTINA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 304
  • TABLE 548 ARGENTINA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 305
  • TABLE 549 PERU TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 306
  • TABLE 550 PERU PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 306
  • TABLE 551 PERU TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 306
  • TABLE 552 PERU TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 306
  • TABLE 553 PERU TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 307
  • TABLE 554 PERU PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 307
  • TABLE 555 PERU DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 307
  • TABLE 556 PERU CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 307
  • TABLE 557 PERU TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 308
  • TABLE 558 PERU ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 308
  • TABLE 559 PERU GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 308
  • TABLE 560 PERU TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 308
  • TABLE 561 PERU TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 308
  • TABLE 562 PERU RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 309
  • TABLE 563 REST OF SOUTH AMERICA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 310
  • TABLE 564 MIDDLE EAST AND AFRICA TAXANE MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 316
  • TABLE 565 MIDDLE EAST AND AFRICA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 316
  • TABLE 566 MIDDLE EAST AND AFRICA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 316
  • TABLE 567 MIDDLE EAST AND AFRICA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 316
  • TABLE 568 MIDDLE EAST AND AFRICA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 317
  • TABLE 569 MIDDLE EAST AND AFRICA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 317
  • TABLE 570 MIDDLE EAST AND AFRICA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 317
  • TABLE 571 MIDDLE EAST AND AFRICA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 317
  • TABLE 572 MIDDLE EAST AND AFRICA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 318
  • TABLE 573 MIDDLE EAST AND AFRICA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 318
  • TABLE 574 MIDDLE EAST AND AFRICA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 318
  • TABLE 575 MIDDLE EAST AND AFRICA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 318
  • TABLE 576 MIDDLE EAST AND AFRICA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 318
  • TABLE 577 MIDDLE EAST AND AFRICA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 319
  • TABLE 578 MIDDLE EAST AND AFRICA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 319
  • TABLE 579 SOUTH AFRICA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 320
  • TABLE 580 SOUTH AFRICA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 320
  • TABLE 581 SOUTH AFRICA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 320
  • TABLE 582 SOUTH AFRICA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 320
  • TABLE 583 SOUTH AFRICA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 321
  • TABLE 584 SOUTH AFRICA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 321
  • TABLE 585 SOUTH AFRICA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 321
  • TABLE 586 SOUTH AFRICA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 321
  • TABLE 587 SOUTH AFRICA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 322
  • TABLE 588 SOUTH AFRICA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 322
  • TABLE 589 SOUTH AFRICA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 322
  • TABLE 590 SOUTH AFRICA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 322
  • TABLE 591 SOUTH AFRICA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 322
  • TABLE 592 SOUTH AFRICA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 323
  • TABLE 593 EGYPT TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 324
  • TABLE 594 EGYPT PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 324
  • TABLE 595 EGYPT TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 324
  • TABLE 596 EGYPT TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 324
  • TABLE 597 EGYPT TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 325
  • TABLE 598 EGYPT PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 325
  • TABLE 599 EGYPT DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 325
  • TABLE 600 EGYPT CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 325
  • TABLE 601 EGYPT TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 326
  • TABLE 602 EGYPT ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 326
  • TABLE 603 EGYPT GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 326
  • TABLE 604 EGYPT TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 326
  • TABLE 605 EGYPT TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 326
  • TABLE 606 EGYPT RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 327
  • TABLE 607 SAUDI ARABIA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 328
  • TABLE 608 SAUDI ARABIA PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 328
  • TABLE 609 SAUDI ARABIA TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 328
  • TABLE 610 SAUDI ARABIA TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 328
  • TABLE 611 SAUDI ARABIA TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 329
  • TABLE 612 SAUDI ARABIA PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 329
  • TABLE 613 SAUDI ARABIA DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 329
  • TABLE 614 SAUDI ARABIA CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 329
  • TABLE 615 SAUDI ARABIA TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 330
  • TABLE 616 SAUDI ARABIA ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 330
  • TABLE 617 SAUDI ARABIA GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 330
  • TABLE 618 SAUDI ARABIA TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 330
  • TABLE 619 SAUDI ARABIA TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 330
  • TABLE 620 SAUDI ARABIA RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 331
  • TABLE 621 U.A.E TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 332
  • TABLE 622 U.A.E PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 332
  • TABLE 623 U.A.E TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 332
  • TABLE 624 U.A.E TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 332
  • TABLE 625 U.A.E TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 333
  • TABLE 626 U.A.E PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 333
  • TABLE 627 U.A.E DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 333
  • TABLE 628 U.A.E CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 333
  • TABLE 629 U.A.E TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 334
  • TABLE 630 U.A.E ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 334
  • TABLE 631 U.A.E GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 334
  • TABLE 632 U.A.E TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 334
  • TABLE 633 U.A.E TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 334
  • TABLE 634 U.A.E RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 335
  • TABLE 635 ISRAEL TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 336
  • TABLE 636 ISRAEL PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 336
  • TABLE 637 ISRAEL TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 336
  • TABLE 638 ISRAEL TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 336
  • TABLE 639 ISRAEL TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 337
  • TABLE 640 ISRAEL PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 337
  • TABLE 641 ISRAEL DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 337
  • TABLE 642 ISRAEL CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 337
  • TABLE 643 ISRAEL TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 338
  • TABLE 644 ISRAEL ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 338
  • TABLE 645 ISRAEL GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 338
  • TABLE 646 ISRAEL TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 338
  • TABLE 647 ISRAEL TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 338
  • TABLE 648 ISRAEL RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 339
  • TABLE 649 KUWAIT TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 340
  • TABLE 650 KUWAIT PACLITAXEL IN TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 340
  • TABLE 651 KUWAIT TAXANE MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 340
  • TABLE 652 KUWAIT TAXANE MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION) 340
  • TABLE 653 KUWAIT TAXANE MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 341
  • TABLE 654 KUWAIT PACLITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 341
  • TABLE 655 KUWAIT DOCETAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 341
  • TABLE 656 KUWAIT CARBAZITAXEL IN TAXANE MARKET, BY STRENGTH, 2020-2029 (USD MILLION) 341
  • TABLE 657 KUWAIT TAXANE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 342
  • TABLE 658 KUWAIT ADULT IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 342
  • TABLE 659 KUWAIT GERIATRIC IN TAXANE MARKET, BY GENDER, 2020-2029 (USD MILLION) 342
  • TABLE 660 KUWAIT TAXANE MARKET, BY END USER, 2020-2029 (USD MILLION) 342
  • TABLE 661 KUWAIT TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 342
  • TABLE 662 KUWAIT RETAIL SALES IN TAXANE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 343
  • TABLE 663 REST OF MIDDLE EAST AND AFRICA TAXANE MARKET, BY TYPE, 2020-2029 (USD MILLION) 344

LIST OF FIGURES

  • FIGURE 1 GLOBAL TAXANE MARKET: SEGMENTATION 46
  • FIGURE 2 GLOBAL TAXANE MARKET: DATA TRIANGULATION 49
  • FIGURE 3 GLOBAL TAXANE MARKET: DROC ANALYSIS 50
  • FIGURE 4 GLOBAL TAXANE MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 51
  • FIGURE 5 GLOBAL TAXANE MARKET: COMPANY RESEARCH ANALYSIS 51
  • FIGURE 6 GLOBAL TAXANE MARKET: INTERVIEW DEMOGRAPHICS 52
  • FIGURE 7 GLOBAL TAXANE MARKET: MARKET APPLICATION COVERAGE GRID 53
  • FIGURE 8 GLOBAL TAXANE MARKET: DBMR MARKET POSITION GRID 55
  • FIGURE 9 GLOBAL TAXANE MARKET: VENDOR SHARE ANALYSIS 57
  • FIGURE 10 GLOBAL TAXANE MARKET: SEGMENTATION 61
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL TAXANE MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 62
  • FIGURE 12 INCREASING INVESTMENT FOR HEALTHCARE INFRASTRUCTURE IS EXPECTED TO DRIVE THE GLOBAL TAXANE MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 63
  • FIGURE 13 THE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TAXANE MARKET IN 2022 & 2029 63
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL TAXANE MARKET 75
  • FIGURE 15 INCIDENCE OF BREAST CANCER IN 2020 76
  • FIGURE 16 GLOBAL TAXANE MARKET: BY TYPE, 2021 84
  • FIGURE 17 GLOBAL TAXANE MARKET: BY TYPE, 2022-2029 (USD MILLION) 85
  • FIGURE 18 GLOBAL TAXANE MARKET: BY TYPE, CAGR (2022-2029) 85
  • FIGURE 19 GLOBAL TAXANE MARKET: BY TYPE, LIFELINE CURVE 86
  • FIGURE 20 GLOBAL TAXANE MARKET: BY APPLICATION, 2021 93
  • FIGURE 21 GLOBAL TAXANE MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 94
  • FIGURE 22 GLOBAL TAXANE MARKET: BY APPLICATION, CAGR (2022-2029) 94
  • FIGURE 23 GLOBAL TAXANE MARKET: BY APPLICATION, LIFELINE CURVE 95
  • FIGURE 24 GLOBAL TAXANE MARKET: BY DRUG TYPE, 2021 101
  • FIGURE 25 GLOBAL TAXANE MARKET: BY DRUG TYPE, 2022-2029 (USD MILLION) 102
  • FIGURE 26 GLOBAL TAXANE MARKET: BY DRUG TYPE, CAGR (2022-2029) 102
  • FIGURE 27 GLOBAL TAXANE MARKET: BY DRUG TYPE, LIFELINE CURVE 103
  • FIGURE 28 GLOBAL TAXANE MARKET: BY FORMULATION, 2021 107
  • FIGURE 29 GLOBAL TAXANE MARKET: BY FORMULATION, 2022-2029 (USD MILLION) 108
  • FIGURE 30 GLOBAL TAXANE MARKET: BY FORMULATION, CAGR (2022-2029) 108
  • FIGURE 31 GLOBAL TAXANE MARKET: BY FORMULATION, LIFELINE CURVE 109
  • FIGURE 32 GLOBAL TAXANE MARKET: BY AGE GROUP, 2021 114
  • FIGURE 33 GLOBAL TAXANE MARKET: BY AGE GROUP, 2022-2029 (USD MILLION) 115
  • FIGURE 34 GLOBAL TAXANE MARKET: BY AGE GROUP, CAGR (2022-2029) 115
  • FIGURE 35 GLOBAL TAXANE MARKET: BY AGE GROUP, LIFELINE CURVE 116
  • FIGURE 36 GLOBAL TAXANE MARKET: BY END USER, 2021 121
  • FIGURE 37 GLOBAL TAXANE MARKET: BY END USER, 2022-2029 (USD MILLION) 122
  • FIGURE 38 GLOBAL TAXANE MARKET: BY END USER, CAGR (2022-2029) 122
  • FIGURE 39 GLOBAL TAXANE MARKET: BY END USER, LIFELINE CURVE 123
  • FIGURE 40 GLOBAL TAXANE MARKET: BY DISTRIBUTION CHANNEL, 2021 128
  • FIGURE 41 GLOBAL TAXANE MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 129
  • FIGURE 42 GLOBAL TAXANE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 129
  • FIGURE 43 GLOBAL TAXANE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 130
  • FIGURE 44 GLOBAL TAXANE MARKET: SNAPSHOT (2021) 135
  • FIGURE 45 GLOBAL TAXANE MARKET: BY REGION (2021) 137
  • FIGURE 46 GLOBAL TAXANE MARKET: BY REGION (2022 & 2029) 137
  • FIGURE 47 GLOBAL TAXANE MARKET: BY REGION (2021 & 2029) 138
  • FIGURE 48 GLOBAL TAXANE MARKET: BY TYPE (2022-2029) 138
  • FIGURE 49 NORTH AMERICA TAXANE MARKET: SNAPSHOT (2021) 141
  • FIGURE 50 NORTH AMERICA TAXANE MARKET: BY COUNTRY (2021) 143
  • FIGURE 51 NORTH AMERICA TAXANE MARKET: BY COUNTRY (2022 & 2029) 143
  • FIGURE 52 NORTH AMERICA TAXANE MARKET: BY COUNTRY (2021 & 2029) 144
  • FIGURE 53 NORTH AMERICA TAXANE MARKET: BY TYPE (2022-2029) 144
  • FIGURE 54 EUROPE TAXANE MARKET: SNAPSHOT (2021) 162
  • FIGURE 55 EUROPE TAXANE MARKET: BY COUNTRY (2021) 164
  • FIGURE 56 EUROPE TAXANE MARKET: BY COUNTRY (2022 & 2029) 164
  • FIGURE 57 EUROPE TAXANE MARKET: BY COUNTRY (2021 & 2029) 165
  • FIGURE 58 EUROPE TAXANE MARKET: BY TYPE (2022-2029) 165
  • FIGURE 59 ASIA-PACIFIC TAXANE MARKET: SNAPSHOT (2021) 236
  • FIGURE 60 ASIA-PACIFIC TAXANE MARKET: BY COUNTRY (2021) 238
  • FIGURE 61 ASIA-PACIFIC TAXANE MARKET: BY COUNTRY (2022 & 2029) 238
  • FIGURE 62 ASIA-PACIFIC TAXANE MARKET: BY COUNTRY (2021 & 2029) 239
  • FIGURE 63 ASIA-PACIFIC TAXANE MARKET: BY TYPE (2022-2029) 239
  • FIGURE 64 SOUTH AMERICA TAXANE MARKET: SNAPSHOT (2021) 290
  • FIGURE 65 SOUTH AMERICA TAXANE MARKET: BY COUNTRY (2021) 292
  • FIGURE 66 SOUTH AMERICA TAXANE MARKET: BY COUNTRY (2022 & 2029) 292
  • FIGURE 67 SOUTH AMERICA TAXANE MARKET: BY COUNTRY (2021 & 2029) 293
  • FIGURE 68 SOUTH AMERICA TAXANE MARKET: BY TYPE (2022-2029) 293
  • FIGURE 69 MIDDLE EAST AND AFRICA TAXANE MARKET: SNAPSHOT (2021) 312
  • FIGURE 70 MIDDLE EAST AND AFRICA TAXANE MARKET: BY COUNTRY (2021) 314
  • FIGURE 71 MIDDLE EAST AND AFRICA TAXANE MARKET: BY COUNTRY (2022 & 2029) 314
  • FIGURE 72 MIDDLE EAST AND AFRICA TAXANE MARKET: BY COUNTRY (2021 & 2029) 315
  • FIGURE 73 MIDDLE EAST AND AFRICA TAXANE MARKET: BY TYPE (2022-2029) 315
  • FIGURE 74 GLOBAL TAXANE MARKET: COMPANY SHARE 2021 (%) 345
  • FIGURE 75 NORTH AMERICA TAXANE MARKET: COMPANY SHARE 2021 (%) 346
  • FIGURE 76 EUROPE TAXANE MARKET: COMPANY SHARE 2021 (%) 347
  • FIGURE 77 ASIA-PACIFIC TAXANE MARKET: COMPANY SHARE 2021 (%) 348